News

Video

ASCRS 2025: Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications

The retrospective study assessed corneal cross-linking complications at Wills Eye Hospital from 2018 to 2023.

At the American Society of Cataract and Refractive Surgery (ASCRS) annual meeting in Los Angeles, California, the Eye Care Network met with Weijie Violet Lin, MD, ABO. An assistant professor at the Weill Cornell department of ophthalmology in New York, Dr. Lin was previously a cornea fellow at Wills Eye Hospital in Philadelphia, Pennsylvania.

Her presentation focused on a study of cross-linking complications at Wills Eye Hospital over a 5-year time period, ranging from 2018 to 2023. The research focused on persistent epithelial defects, corneal haze, and infiltrates.

Dr. Lin shared findings about the complications, including assessments of socioeconomic factors and their impact on patient outcomes. She also highlighted applicable clinical insights from the research, such as pearls for prioritizing patients with specific risk factors. "For some of those patients that do have these factors that we're seeing are more likely to be associated with development of complications, I would consider putting those patients first in the line for epi-on crosslinking when it becomes available," Dr. Lin advised.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
Alex Hacopian, MD, discusses a presbyopia-correcting IOL at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Parag Majmudar, MD, on bridging the gap between residency and real-world practice
© 2025 MJH Life Sciences

All rights reserved.